Introduction:
Hypertensive disorders during pregnancy are important causes of severe morbidity, long-term disability, and death of both mothers and their babies. About 10 percent of the women experience increased blood pressure during pregnancy and less than 8 percent pregnancies get complicated by preeclampsia. Among the preeclampsia patients, about 10 percent develop severe preeclampsia and eclampsia. Globally, about 10-20 percent maternal deaths are associated with eclampsia 1 . The majority of deaths of mothers and their babies caused by severe preeclampsia and eclampsia (PE/E) are preventable through provision of timely and effective medical care. 2 Pre-eclampsia is a multi-system disorder of unknown etiology characterized by development of hypertension to the extent of 140/90 mmHg or more with proteinuria after 20 th week of gestation in a previously normotensive and non-protein uric pregnant woman. Pre-eclampsia has been associated with intrauterine growth retardation, preterm birth, maternal and perinatal death.
Globally, every day, more than 800 women, die from preventable complications related to pregnancy, childbirth and other causes, and 7,300 women experience a stillbirth (Lancet 2016). About In developing countries, a woman is seven times as likely as to develop preeclampsia than a woman in a developed country. From 10-25 percent of these cases will result in maternal death (WHO 2007) .
Pakistan Perspective
Magnitude of the Problem (Maternal morbidity and mortality trends) Pakistan is one of the six countries that account for more than 50% of the world's maternal deaths (Hogan et al. 2010 ). According to Population Council estimates, each year, nearly 8.6 million women become pregnant in the country. Of these, 15%, i.e., 1.2 million women are likely to face obstetric complications (Sathar et al. 2013) . Each year, there are nearly 14,000 pregnancy-related deaths (PRDs), which means on average one maternal death occurs every 40 minutes. Pakistan has also one of the highest neonatal mortality rates in the world at 55 per 100,000 live births. In KP, the NMR is 41 per 1,000 live births.3 so large sample sizes are required for estimates to be reliable. For the same reason, measuring maternal mortality is also expensive. Secondly, at present there is no standard method that can be universally applied for measuring mortality; while various techniques have already been proposed or used to estimate maternal mortality in Pakistan, each has its limitations.
Ideally a vital registration system is the most accurate way of estimating maternal mortality, provided the system includes questions on cause of death and deaths are fully recorded. In Pakistan the vital registration system is still in the process of development and there is no provision for mandatory registration of deaths. Including mortality questions in the census questionnaire is a potentially comprehensive alternative method for measuring maternal deaths. However, this question has yet not been included in Pakistan, and would require considerable training of enumerators/interviewers to ensure a full count.
Many countries with deficient vital registration, including Pakistan, have used indirect techniques to generate maternal mortality estimates, such as conducting household surveysthe next best option to vital registration. However, to measure maternal mortality, household surveys must have a large sample size and they are therefore expensive undertakings, not easy to repeat regularly.
The indirect sisterhood method, which can be included in surveys with relatively smaller samples, uses reports by adults about aggregate numbers of surviving and deceased sisters, with additional questions related to the timing of death. This method identifies PRDs but tends to underestimate overall mortality because of inherent biases in data collection. More recently, direct sibling based methods have been introduced that provide all information required to estimate pregnancy-related mortality, including fertility, and also provide estimates of all female and male causes of mortality between the ages of 15 and 50. However, they are at best able to produce national level estimates, since they generate large sampling errors.
Reproductive age mortality studies (RAMOS) were considered in the past as the gold standard for measuring maternal mortality. They involve systematic efforts to combine data on maternal deaths from multiple sources including vital registration, medical records, traditional birth attendants (TBAs), graveyard records, and verbal autopsies. RAMOS allow for important data collection on avoidable causes of deaths both at home and at the facility. However, these studies are complex, expensive, labor-intensive and largely applicable in settings with at least 60% completeness of reporting of adult female deaths in vital registration. Moreover, they do not provide a number of births for estimating the MMR and have rarely been carried out at a national level except in Egypt, Honduras and Guatemala . 6, 7 There is lack of information on context-specific health system barriers that prevent optimal use of the lifesaving medicine (magnesium sulfate) in Pakistan. Recent empirical evidence generated by a study, carried out in Pakistan, found that while international recommendations on MgSO4 have been adequately translated in national policies in Pakistan, the gap remains in implementation of national policies into practice. In Pakistan, although efforts both at the national and sub-national levels are ongoing on the prevention and treatment of PE/E, results are generally suboptimal and program interventions remain uncoordinated and fragmented. In several countries, poor procurement and distribution systems are responsible for low availability of the drug. In Pakistan, a study found that a fragmented system for registration, procurement and distribution was at the source of the low use of magnesium sulfate even though policies were all aligned with international standards (Bigdeli et al., 2013) .
To fully appreciate the enormity of the problem at country level, we conducted a systematic review of published papers on PE/E in Pakistan from 2005-2015 in order to understand the key challenges, gaps and interventions related to the prevention and treatment of preeclampsia and eclampsia.
In recent years, the need for more precise sub-national estimates has increased. Post devolution after the 18th Constitutional Amendment, the provincial health departments are responsible for identifying priorities and developing provincial policies. Districts have also been empowered to develop their own health plans and seek the required allocation of resources from the district administration. The availability of reliable MMR estimates at both provincial and district level is essential for planning, monitoring, and evaluating maternal healthcare interventions.
Material & Methods:
We searched PubMed; Google Scholar; Medline/POPLINE; Science Direct; Cochrane; World Health Organization Library Information System (WHOLIS) and all databases available through EBSCO Host of original articles published between January 2000 and June 2015.
Inclusion criteria
The overall selection criteria for this literature review were set in line with the study objectives of Landscape analysis on prevention and management of Preeclampsia/Eclampsia in Pakistan. Inclusion criteria of the literature include: studies published between 2000 and 2015, publication in English and peer reviewed and publications should have a focus on trials on preeclampsia, eclampsia, hypertension during pregnancy, use of loading dose of MgSO4 during SPE/E, the use of Aspirin prophylaxis for pregnant women at risk of developing PE/E, use of antihypertensive during pregnancy period, and use of loading dose of MgSO4 at the community/PHC level. This systematic literature review was conducted in three phases to collect, organize and analyze the published literature on pre-eclampsia and eclampsia in Pakistan between 2000 and 2015.
Exclusion Criteria Documents older than 2000 were not included in the review. Moreover documents which did not directly discuss the objective of the review were also excluded. In addition to this, some documents had too small sample size and some were not discussing PE/E in detail, these were also excluded.
Phase I: Title & abstract Screening
During the phase one two independent reviewers conducted title and abstract screening to determine that abstracts should be included or excluded in the next phase of the review. Abstracts were excluded if they were: 1) Not about Pakistan, 2) Not related to pregnancy; (for example: abstracts about male subjects and abstracts that discussed hypertension but not in pregnancy were excluded) 3) Not related to PE/E or associated risk factors, symptoms, or complications.
PHASE II: Review of Complete Articles
In the second phase, the two reviewers read the full text of the articles to determine their relevance and eliminated any papers that were based on data collected prior to 2000.
PHASE III: Analysis
Finally, the remaining articles were sorted into four types of papers-based on the main topic of each-that were found during the systematic review.
1. Descriptive Papers: case reviews, project reports, literature reviews etc. 
RESULTS
After being screened as the most relevant documents 226 Abstracts were selected and reviewed. 11766 articles were excluded from the review. The detail is as under:-A total of 11,766 searches were made in the following websites:-Pubmed, Cochrane, Science Direct, Popline and Wiley Online Library.
Google emerged with 85,900 searches of Eclampsia and 69, 100 searches of Pre-eclampsia in Pakistan. However it was not possible to peruse all documents thoroughly, therefore selected study was made of the most relevant documents.
The most relevant data was found in 226 reports of these websites. 
Risk Factors
The reviewed literature highlights different risk factors for developing PE/E. According to three studies, pre-eclampsia occurs as a complication of pregnancy while Eclampsia occurs only as complication of Pre-eclampsia. Pre-eclampsia is most often seen in first pregnancy, teen age pregnancy or 40 years above pregnancy. It is a common pregnancy associated disorder especially in primigravida and teenagers [1, 2, 3] . Nulliparity, Multiparty/Multiple pregnancies and twin pregnancies also cause preeclampsia as per five other cross sectional research studies [4, 5, 6, 7, 8] .
According to Cross-sectional observational studies, pregnancy induced hypertension the leading risk factor for developing Pre-eclampsia is also found in metformin treated groups [9, 10] . The frequency of presence of Breast Arterial Calcifications-BAC on mammography is also associated with systemic hypertension and higher age [11] . The risk for developing Pre-eclampsia was seen to be increased, with an interval of 10 years or more, from the previous pregnancy.
The assessment studies show that development of preeclampsia is associated with gestational diabetes pre-gestational diabetes, family history of hypertension, chronic hypertension, raised body mass index before pregnancy or at booking, mental stress during pregnancy, autoimmune disease, renal disease, fetal malformation and use of anti-depressive. Insulin dependent diabetes (IDDM) and Antiphospholipid syndrome also serve as risk factors for pre-eclampsia [12, 13, 14, 15] . It also occurs due to food intake practices, food group consumption, and avoidance of any food, craving, aversion to any sort of food and/or non-consumption of adequate food [8] . Two more descriptive and prospective studies show that other risk factors leading towards pre-eclampsia are Doppler abnormalities & biomarkers [14] , Amniotic Fluid Index [16] and parity [17] .
In addition to the above, lipid metabolism, increased triglycerides levels along with decreased HDLcholesterol levels and delayed triglycerides clearance are also associated with the development of preeclampsia [17] . Similarly, two facility based research studies show that raised levels of serum bilirubin and liver enzymes ALT, AST and ALK/HELLP Syndrome are a cause in women with Preeclampsia [18, 19] .
Six cross sectional and case studies conducted at health facilities show that other than the medicinal ones, there are some other potential risk factors for developing PE/E. These are poverty [20, 21, 22, 23, 24, 25] illiteracy, low household income, unemployment, depressions, stress and gender inequality in Pakistan [26] .
Outcomes of PE/E
Pakistan along with six other developing countries contributes to 50% of world's maternal deaths. Globally, maternal death occurs during childbirth in 11-17% cases while 50-71% deaths occur in the postpartum period. Majority of these deaths are avoidable [26] .
Hypertensive disorders of pregnancy are a major cause of maternal and perinatal mortality and morbidity [25, 27,] . In Pakistan, its incidence and related mortality are high due to lack of adequate antenatal care and awareness. [28, 29, 30] .
There are severe and frequent pathological changes in preeclampsia and eclampsia cases [31] . The adverse effects of PE/E include edema, headache, seizure, and death [28, 32, 33, 34] . The other health outcomes of PE/E include intrauterine growth restriction and still birth [35, 36, 37, 38, Acute Kidney Injury-AKI is a frequently occurring complication in developing countries which ranges from 4% to 36%. In India and Pakistan, pregnancy-related AKI occurs mainly during the first trimester. These are related to severe states of sepsis. In Morocco, AKI occurs mainly in the third trimester in a context of hypertensive disorders. Total recovery of renal function depends on early and appropriate diagnosis and treatment. Prevention is the best strategy in this regard [48] .
In addition to the above, in a number of cross-sectional studies it was estimated that pregnancy related Acute Renal Failure-ARF is the most common outcomes of PE/E and is a dangerous complication of pregnancy which carries very high mortality and morbidity [49, 50, 44, 51, 52, 53] .
With regards to other outcomes of PE/E, there is a significant clinical correlation between pregnancyinduced hypertension, abruptio placentae [54, 55, 56] and proteinuria [57] . (A patient's eight and/or 12-hour urine total protein values correlate with the 24-hour value to confirm the diagnosis of preeclampsia).
Exposure to PE/E also leads to raised Serum Bilirubin and Liver Enzymes/HELLP Syndrome [18] , peripheral arterial disease [58] , low APGAR score 8 , Intra-uterine Death, low birth weight and perinatal death [59, 60] . Moreover, there are higher levels of serum leptin and higher levels of homocysteine in pregnancies complicated by pre-eclampsia and eclampsia [61] .
In the same context, increased BMI [62] , Renal, Cortical Necrosis [63] and elevated plasma leptin concentration appear to be a marker of pre-eclampsia independently or along with other parameters of pre-eclampsia [64] . In addition to these, loss of vision (Blurry vision and flashing lights, and floaters) are the other outcomes of eclampsia [65] . The literature also shows that there is strong association between preterm abruption and pre-eclampsia [66] .
PE/E ends up in delivery/pre-term delivery which is mainly Caesarian. A study was conducted in 2005 [67] in Peshawar Pakistan. The objective of this study was to determine the rate and clinical indications for emergency and elective caesarean section. The study shows that most of the caesarean sections were emergency caesarean sections. The rate of caesarean section was only slightly higher than recommended by the WHO (Naeem, 2015) . Out of 22% caesarean sections 6% were due to pregnancy induced hypertension. Maternal morbidity in emergency versus elective caesarean section is significantly higher [68] . New-born resuscitation is required in such kind of high risk pregnancies and personnel trained in newborn resuscitation should be available at the time of delivery [69] .
Evidences from Cases
Malignant ovarian germ cell tumors at a tertiary care setting in Pakistan were studied [70] to see the frequency of placental infarcts in hypertensive preterm pregnancies and its effects on foetal outcomes (Hanan, 2015) . Case records of 66 patients from 1994-2007 with MOGCT were reviewed. Findings highlight that histologically, dysgerminoma was the most common diagnosis followed by teratoma, yolk sac tumor, mixed germ cell tumor and embryonal carcinoma. The latter was found only in one patient. Median follow-up was 48 months. All patients underwent initial surgery. Fertility sparing procedures were performed in 75% patients. 58% patients achieved complete remission while 27% had progressive disease. 11% patients relapsed, all within first 3 years. Sixteen (88%) of stage I while only 4 (26.6%) of stage IV patients were alive at median follow-up (Hanan, 2015).
A case study conducted to assess maternal and perinatal outcome in nulliparious women complicated with pregnancy hypertension [71 shows that there were no significant differences in maternal age, menstruation condition, delivery mode, placental detachment rate between the studied groups. Gestational age was significantly lower in the case group, especially in severe preeclampsia subgroup. Serum creatinine level more than 1.2 mg/dl was significantly higher in mild and severe preeclampsia groups. Significant differences were found in neonatal APGAR, need of resuscitation, NICU admission, birth weight and length, LBW and intrauterine growth retardation between the studied groups.
Detection
The severity of PE/E can be avoided through early/timely detection of the disease. Correct diagnosis and timely intervention can decrease the risk of maternal and perinatal mortality owing to PE/E. Factors like gestational diabetes, pre-gestational diabetes, family history of hypertension and mental stress during pregnancy can be used as a screening tool for pre-eclampsia prediction to timely diagnose and monitor women likely to develop preeclampsia before the onset of disease. This would facilitate timely interventions and ensure better maternal and fetal outcomes [1, 93] .
PE can be predicted in primiparas in the early part of second trimester with serum levels of sFlt-1 9 and in the later part of second trimester with serum levels of Placental Growth Factor-PlGF 10 [94] . As early diagnosis [48, 95, 72, 96] can lead to early treatment, it is utmost necessary to diagnose early for which routine antenatal check-up is a crucially important strategy.
In addition to the above, imaging also plays a primary role in the diagnosis of cerebral venous sinus thrombosis because the clinical picture of CVST is non-specific and highly variable [97] . Clinical presentation of the patient is most important in diagnosing viral encephalitis in postnatal women especially when patient presents with fever, altered sensorium and convulsions [98] . There should be multiple suppliers of MgSO4. Its use should be enhanced by rewarding those who are using it. Moreover, advocacy should be made for the accessibility and use of magnesium sulfate in the country.
Treatment
Magnesium Sulphate (MgSO4) is the best way to treat PE/E than other anti-convulsants. Initial loading dose of magnesium sulphate not only prevents but also treats Eclampsia. MgSO4 is low-cost. Moreover subsequent follow up of MgSO4 is also easier. Therefore, MgSO4 is appropriate for use by PHC Providers. However, the dosage and duration of MgSO4 therapy should be decided after keeping in mind the local context [99] .
MgSO4 acts as a vasodilator, with actions in the peripheral vasculature or the cerebrovasculature. It decreases peripheral vascular resistance and also relieves vasoconstriction. Moreover, MgSO4 also protects the blood-brain barrier and limits cerebral edema formation. It also acts through a central There are certain clinical requirements for the use of magnesium sulfate, which include the availability of infusion pumps for I/V use, dosage preparation, availability of the antidote calcium gluconate and understanding the contra-indication to use especially alongside diazepam. Magnesium levels are not required routinely for its use. This clearly demonstrates that along with the formulation of clinical guidelines, procedures need to be in place at facility level with relevant staff trained and equipment available [102].
Pakistan Perspective
In Pakistan, 10 grams (10 ml or 01 ampule) of MgSO Injection is given as a loading dose (5gms in each 4 buttock I/M) and this is diluted with 10 ml of normal saline and 2 % xylocaine injection i.e. total of 10 grams is given. Antidote is Calcium Gluconate Injection 10 ml given slowly I/V over 10 minutes.
Loading Dose of MgSO4
Challenges in the use of MgSO4:
While international recommendations on MgSO4 have been adequately translated in national policies in Pakistan, gap remains in the implementation of national policies into practice. Barriers to access to and effective use of MgSO4 occur at health facility level where the medicine is not available and health staff is reluctant to use it. Low price of the medicine and the small market related to its narrow indications also act as disincentives for the effective marketing of MgSO4 [118] . Due to these reasons like in many other Low-and Middle-Income Countries, MgSO4 is enormously under-utilized in Pakistan.
There are context-specific health system barriers that prevent optimal use of this life-saving medicine, which should be removed to enhance the use of MgSO4 [119] .
Supply of MgSO4 is interrupted sometimes and provinces face shortage of the same. The preparation of its dosage is also difficult. Moreover there are misconceptions about its use among the senior Obstetricians.
Other than medicinal one, to balance the timing of delivery of patients with pre-eclampsia before the onset of eclampsia is also a major challenge [120].
Magnesium sulfate is on WHO's essential medicines list since 1996 and since 2003 which has specifically been included for the treatment of severe pre-eclampsia and eclampsia. If MgSO4 is used appropriately in Pakistan it can bring about a significant reduction in the maternal mortality and morbidity rates [121, 122] .
Strategies to reduce PE/E Short term, medium term and longer term Strategies need to be developed based on competencybased training and deployment and supervision of a cadre of skilled attendants for delivery at the community level. In addition upgrading of health care systems especially availability of emergency obstetric care is urgently required to overcome PE/E and maternal mortality related with it [123] . Thus continued efforts are needed to improve the availability and quality of Emergency Obstetric and Newborn Care through targeted skill-based training [124, 125] and provision of adequate drugs and equipment [124, 126] . There should be proper legislation for this [125] .
Maternal morbidity and mortality can be reduced through safe motherhood programs, provision of separate ICU services for critically ill obstetrical patients and early assessment & intervention through a team work approach involving obstetricians, Intensivists and Anesthetists [127] . Delivery of proper health care system and emergency obstetrical care facilities are vital for the early detection and proper management of PE/E. Provision of skilled care and timely management of complications can reduce maternal mortality in our country [84] . With proper peripartum care, [128] , complete utilization of medical treatment [70] and close monitoring in post-operative period [129] maternal mortality can be reduced.
Long-term mobilization of social structure and governance is also needed to encourage maternal health awareness, hospital deliveries, and formal sector employment for employed mothers [130] .
Providing balanced protein energy and multiple micronutrient supplements to pregnant women will reduce incidence of Intrauterine Growth Restriction -IUGR. Moreover, community-based intervention packages are among the most effective methods of reducing morbidity and mortality in mothers and children [131, 132] . Maternal and newborn care programs should be integrated in community settings through community health workers, self-help groups and health promotion groups. Community-based care should be scaled up through packages to be delivered by community-based workers [132] . Micronutrient malnutrition programs should be integrated in maternal, nutrition and antenatal care programs to maximize outcome [77] . Poverty alleviation and nutritional support programs can be launched for women of reproductive age and all these can also be packaged in the MNCH program [24] .
Linkage of RHMNCH with other health and nutrition programs will bring effective results under maternal and newborn health and save from duplication of efforts and resources in interventions related to PE/E [133] . This will also enhance the efficiency of training, monitoring, and supervision of health care workers dealing with PE/E; it will also help families and communities to access and use health care services providing PE/E treatment easily [133] . Log books to document skill use during emergency obstetric care can be launched and used to measure outcome of PE/E programs and monitor the performance of health care workers and providers [134] .
The literature depicts that sustained investment in health care reforms [135] , political will and partnerships to implement evidence-based PE/E interventions at scale [136], skilled care at facility level and household care at community level for improving maternal, newborn and child survival [137] are the best strategies to reduce PE/E in specific and maternal mortality as a whole.
In addition to the above, it is crucially important to increase the accessibility of ANC services by extending facility working hours and making adjustments according to the convenience of clients in primary healthcare (PHC) facilities. The utilization of ANC services can also be enhanced through community awareness and gender empowerment for ANC decision making [72, 138,] .
Depression is the leading cause of hypertension. To cope with depression during pregnancy, Gynaechologists and Psychiatrists should work together in managing such patients [4] so that it does not lead to hypertension.
Laboratory Services
Elevated plasma leptin concentration appears to be a marker of pre-eclampsia independently or along with other parameters of pre-eclampsia. This can be used to reduce the severity of pre-eclampsia thus avoiding risk effects of pre-eclampsia to mother and foetus [116] . In addition to this, management and delivery of HELLP syndrome patients can be performed at tertiary care centres, where highly trained obstetrician, neonatal intensive care unit personnel and Multi-disciplinary facilities are available [117] .
Community-based Prevention
PE/E can be prevented through routine antenatal examination, availability of health facilities at an ease of access and prompt referral to tertiary care hospital [5, 70, 71, 72] . In order to decrease the adverse outcome of eclampsia a community-based approach is needed to improve community health education, socioeconomic status and prenatal care [73] . In addition to this, delivery of proper health care system and emergency obstetrical care facilities are vital for the prevention of PE/E [73] . Maternal mortality can be reduced with proper peripartum care [29] and skilled care during pregnancy, childbirth, and postnatal period [74] . Assessment of blood lipids is also helpful in the prevention of complications in patients with pregnancy-induced hypertension.
Vitamin -D deficiency and Pre-eclampsia are correlated, therefore, PE can be prevented by overcoming this deficiency and other micronutrient malnutrition [75, 76] like iron and folic acid [77] . Likewise calcium supplementation during pregnancy is associated with reduction in risk of gestational hypertensive disorders, pre-term birth and an increase in birth weight which can also be looked into for interventions aiming to prevent PE/E [78, 79, 80, 81] . However further research is needed to assess its benefit in detail [82] .
In addition to this the creation of increased community demand for health services and increasing their uptake also can play a role in preventing PE/E and its outcomes including stillbirths [83] . Other potential socio-behavioral interventions include birth spacing, smoking cessation and indoor air pollution control, although the evidence for these is weak in the literature [83] . Mitigation of all risk factors identified for still birth and periodontal disease can prevent the outcome of PE/E. Infection control measures, syphilis screening & treatment and malaria prophylaxis in endemic areas are strong interventions for preventing antepartum still births. As still birth is preventable with high quality obstetric care, [84, 85] related interventions should be incorporated into antenatal care programs [86] . Basic and Comprehensive Emergency Obstetric Care are the effective interventions to reduce intrapartum stillbirths though a lot more needs to be done in this regard [87] .
Facility -based Prevention
PE/E can also be prevented through facility level interventions. Up-gradation of health facilities including tertiary level hospitals and deployment of senior, skilled and experienced personnel in the management of obstetrics emergencies can effectively reduce caesarean section rate and maternal morbidity & mortality. This would ultimately improve fetal outcome as well [48] . Moreover, community sensitization for early antenatal booking and provision of emergency obstetric care services at door step will also improve obstetric outcome [88] .
Importance of Public Health initiatives
Importance of public health interventions for preventing PE/E can also not be denied. Improving education, nutrition, and uniform implementation of obstetric care protocols are needed for better maternal and neonatal health in Pakistan [89] . Focus of attention should be there on regular ANC and follow up, Vitamin-A Supplementation and Calcium Supplementation, strengthened Referral to tertiary care hospitals and strengthening of the four interlinked health system elements i.e. human resources, access to, use and quality of services is essential though not sufficient strategies for the prevention of PE/E [90, 91] .
Improving education, nutrition, and uniform implementation of obstetric care protocols are needed for better maternal and neonatal health in Pakistan [92] . Gender empowerment, decision making and provision of adequate drugs & equipment at health facilities are the best strategies to prevent or reduce PE/E.
Procurement and Distribution:
The medicine is procured by Ministry of National Health Services Regulation and Coordination. There is no budget allocated to the provinces whereas the medicine is directly procured by the provinces. Other than MgSO4, use of low dose aspirin and low molecular weight heparin is safe in pregnancy and it improves foetal outcome in patients with recurrent pregnancy loss due to anti-phospholipids syndrome [103, 104, 105].
Demand and Supply
Demand According to a study conducted in 2010 (Hafeez, 2010) training and intervention was found to be extremely facilitative factor for the use of MG SO4 even in the non-teaching facilities. Most of the doctors found the dosage preparation to be the biggest barrier to the use of the medicine as they had to recall, calculate and prepare the dosage themselves [102].
Due to lack of training and non-inclusion of the use of MgSO4 in in-service training, there is lack of demand in health care providers with regards to MgSO4. Lack of community awareness is also another factor behind the low demand generation of the medicine.
Supply
Lack of demand is contributing to lack of supply. Before initiating any intervention to improve the management of eclampsia and severe eclampsia Pakistan a thorough understanding of the local context needs to be made. Pakistan is facing constraints in the utilization of MgSO4 due to lack of clinical guidelines, difficult dosage calculation of the medicine and lack of equipment, human resources and trainings.
[102]
MgSO4 needs to be made available to provinces throughout the year by having multiple suppliers.
Moreover prefilled standard dose needs to be purchased to maximize its correct use.
Health System Barriers in the use of MgSO4 in Pakistan Lack of procurement, lack of availability and inadequate and improper use of MgSO4 is the greatest barrier in the use of this medicine in Pakistan. Other common barriers are complex dosing regimens, a lack of product harmonization, low familiarity of the drug, and hesitation of health care providers to administer MgSO4 due to its perceived side effects, all of which limit its impact. Yet another barrier is delay in the administration of second dose in case of referral.
Other than the above, lack of training is adversely affecting the treatment of PE/E. according to a study conducted in 2010 (Hafeez, 2010) some of the teaching hospitals were found to be using diazepam and MgSO4 together for admitted eclampsia patients. This was against the standard treatment guidelines and it was dangerous to use this medicine in such a way. Some of the staff working in the non-teaching settings had received EmNOC trainings by MNCH program which had enhanced their awareness on the use of MgSO4. However, the lower level hospitals providing maternal care were better equipped and were using MgSO4 injections for eclampsia.
Community Review/Case Studies
A Study Frequency and Impact of Hypertensive Disorders of Pregnancy [27] conducted in 2014 (Parveen M. Aabidha, 2015) shows that total deliveries during study period were 2702. Out of 2702 deliveries 150 (5.5%) mothers were hypertensive. Out of 150 hypertensive cases 30% were cases of gestational hypertension, 58% were cases of toxemia of pregnancy and 12% were cases of chronic hypertension. Maternal age, gravida, parity was lowest in toxemia of pregnancy group. Commonest maternal complication was eclampsia (32%). There were 6 (4%) maternal deaths. Caesarean section was mode of delivery in 54% cases. Thus, hypertension disorders of pregnancy appear to be an important cause of maternal and perinatal mortality and morbidity (Parveen M. Aabidha, 2015).
According to another case study [105] (Sultana, 2005) a total of 2100 admissions were made in the labor ward during this period and out of them 68 cases (3.23%) were of eclampsia. Out of them 28 were primigravida, 14 multigravida and 26 grandmultigravidae. The seasonal frequency of cases was 29.41% in winters, 42.64% in autumn, 19.11% in summers and 8.82% in spring. Out of these 11.76% cases were complicated with retro placental hemorrhage and the same number with aspiration pneumonia, while Cerebrovascular Accident (2.94%) Acute tubular necrosis (2.94%) and Disseminated intravascular clotting (4.4%) were also seen. Among the newborns prematurity was found to be the major cause of perinatal mortality. Eclampsia is a dreadful complication of Pre eclamptic Toxemia of pregnancy associated with high perinatal and maternal mortality. A qualitative and quantitative improvement in prenatal consultation should make it possible to reduce incidence of eclampsia measuring arterial blood pressure daily during antenatal period and for at least 14-days postpartum appears to be necessary for diagnosis and treatment for all cases of hypertension.
Other case studies [1, 21, 40, 44, 52, 60, 69, 117, [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] illustrate the importance of surgical management of pheochromocytoma in second trimester of pregnancy to avoid catastrophic complications later in pregnancy, high rate of emergency caesarean sections than the elective ones and high prevalence of HCB & HBV among pregnant women etc.
Some other papers also deal with maternal and neonatal mortality, however the same is not specific to PE/E.
Discussion
Skilled based training of the health care providers is crucially important to improve emergency Obstetric and Newborn Care. Along with it continual training and skill-building of TBAs and community health workers is also essential. All should specifically be trained on how to screen pregnant mothers during ANC visits to detect signs of PE/E and how to administer MgSO4 to patients who are in need of anticonvulsant therapy. Before training, training need assessment should be conducted specifically to assess gaps in knowledge and practices.
It is critically important to improve quality of care with regards to the management of PE/E in Pakistan by developing clinical operational guidelines/protocols. Since there is no endorsed guideline/protocol available at national, provincial or regional level, it is the dire need of time to do so. White Ribbon Alliance-WRA Pakistan has formulated Trainees' Manual on the use of Magnesium Sulphate as a first line-treatment in severe Pre-eclampsia and Eclampsia, Pakistan 11 . These guidelines are for doctors working at primary, secondary and tertiary care health facilities. Chapter 5 of this manual illustrates Use of Magnesium Sulphate in detail.
In addition to it WHO Recommendations for Prevention and treatment of Pre-eclampsia and Eclampsia are there which also highlight use of Magnesium Sulphate as an effective remedy for PE/E. After evidence, magnesium sulfate was found to be associated with significant reduction both statistically and clinically, in the risk of eclampsia by 59% as compared to placebo and other anticonvulsants.
This shows need for enhanced use of magnesium sulphate for PE/E management with proper guidelines available.
Along with an increase in ANC, skilled delivery, PNC, family planning and nutritional status of mothers would further improve the situation. Gender equality, women empowerment and livelihood programs are also not an exception.
In order to understand the actual situation of PE/E in Pakistan it is important to adopt evidence-based approach and initiate community studies. Community studies through accurate, historical and contextual analysis of community health would enable to understand psycho-social, socio-cultural and socio-economic determinants of PE/E at one hand and barriers to address PE/E at the other. Through grass-root level Research (investigation and observation) at an extensive scale, actual situation can be understood along with adequacy of underway interventions, challenges/barriers and required reforms to prevent and cure PE/E in the country. Allocation of sufficient resources should be made under community studies in all PE/E related interventions therefore.
Research Gaps
None of the studies is adequately and specifically depicting barriers in the availability, preparation, use and follow up of MgSO4 for managing and treating PE/E in Pakistan.
Likewise no study is adequately highlighting how to enhance the use of MgSO4 in Pakistan. Moreover adequate focus of all studies regarding the training of health care providers on the preparation and use of MgSO4 is also missing. The research studies have also not vigorously highlighted the importance of having national level clinical guidelines for the use of MgSO4.
Gaps in the Knowledge Base
Knowledge on the use of MgSO4 to treat PE/E is there as far as health care providers are concerned. However, use of MgSO4 is low. MgSO4 is critically under-utilized in Pakistan. There is a lack of information on context-specific health system barriers that prevents optimal use of this life-saving medicine in Pakistan. Future research needs to be made in this regard as only one paper under review is significantly highlighting these barriers.
Likewise no paper is showing the impact of the use of MgSO4 so that the findings could be disseminated to all stakeholders to maximize the use of medicines. Only one study has shown reasons for the low use of this medicine in detail [122] . This paper has also described some guidelines on the preparation of this medicine [122] .
Similarly no study contains any guideline on the use of MgSO4 though a number of studies have identified the importance of guideline formulation. In the same context, no report significantly describes about frequency of MgSO4 utilization in the health facilities of Pakistan, causes of its low use, demand and supply side interventions of MgSO4, knowledge of health care providers and their willingness on the use of MgSO4, impact of MgSO4 usages (where this medicine has been and is being used), challenges and required reforms in the health care system to make this medicine well utilized. Therefore there are gaps in the evidence.
There is a positive link between Vitamin D deficiencies and Preeclampsia. Vitamin D supplementation can reduce pre-eclampsia. However, further research needs to be conducted to establish this relationship.
In addition to the above, literature is also highlighting research gaps and future research areas. Studies should be conducted to assess: excessive use of micronutrients during pregnancy [189] , triage of preterm and growth restricted infants [131] , benefits of calcium supplementation and aspirin to prevent still birth [82, examine clinical benefits of vitamin B6 supplementation in pregnancy and/or labour [177, 194] , minimize newly recognized risk factors for stillbirth including periodontal [38] , assess the effect of psychotic symptoms with seizure control [202] and assess differences in intraoperative and postoperative hemorrhage when misoprostol is compared to oxytocin [106]. 
Conclusion and Recommendations

